Numinus Applies for Management Cease Trade Order
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) has requested a temporary Management Cease Trade Order (MCTO) from the British Columbia Securities Commission due to delays in filing its audited annual financial statements for the year ended August 31, 2024. The company expects to miss the November 29, 2024 deadline but anticipates completing the Annual Filings by year-end. Numinus will issue bi-weekly status reports during the delay period and has implemented an insider trading blackout. The company confirms it is not under any insolvency proceedings and all material information has been disclosed.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) ha richiesto un Ordine di Stop alla Gestione Temporanea (MCTO) dalla British Columbia Securities Commission a causa di ritardi nell'invio dei propri bilanci annuali certificati per l'anno conclusosi il 31 agosto 2024. L'azienda prevede di non rispettare la scadenza del 29 novembre 2024, ma si aspetta di completare le pratiche annuali entro la fine dell'anno. Numinus emetterà rapporti di stato bisettimanali durante il periodo di ritardo e ha implementato un divieto di trading per gli insider. L'azienda conferma di non essere sotto alcun procedimento d'insolvenza e tutte le informazioni materiali sono state divulgate.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) ha solicitado una Orden de Detención Temporal de Gestión (MCTO) a la British Columbia Securities Commission debido a retrasos en la presentación de sus estados financieros anuales auditados para el año que terminó el 31 de agosto de 2024. La empresa espera no cumplir con la fecha límite del 29 de noviembre de 2024, pero anticipa completar las Presentaciones Anuales para fin de año. Numinus emitirá informes de estado quincenales durante el período de retraso y ha implementado un blackout de comercio para internos. La compañía confirma que no está bajo ningún procedimiento de insolvencia y toda la información material ha sido divulgada.
누미너스 웰니스 (TSX: NUMI, OTCQX: NUMIF)는 2024년 8월 31일로 종료되는 회계연도에 대한 감사된 연간 재무제표 제출 지연으로 인해 브리티시컬럼비아 증권 위원회에 임시 경영 중지 명령 (MCTO)을 요청했습니다. 회사는 2024년 11월 29일 마감일을 맞추지 못할 것으로 예상하지만 연말까지 연례 서류 제출을 완료할 예정입니다. 누미너스는 지연 기간 동안 격주 상태 보고서를 발행하고 내부자 거래 중단을 시행할 것입니다. 회사는 어떠한 파산 절차에도 들어가 있지 않으며 모든 중요한 정보를 공개했다고 확인합니다.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) a demandé un Ordre d'Interdiction de Négociation Temporaire (MCTO) à la British Columbia Securities Commission en raison de retards dans le dépôt de ses états financiers annuels audités pour l'exercice clos le 31 août 2024. L'entreprise prévoit de manquer la date limite du 29 novembre 2024, mais anticipe de compléter les dépôts annuels d'ici la fin de l'année. Numinus publiera des rapports de statut toutes les deux semaines pendant la période de retard et a mis en place un gel de la négociation pour les initiés. L'entreprise confirme qu'elle n'est sous aucune procédure d'insolvabilité et que toutes les informations importantes ont été divulguées.
Numinus Wellness (TSX: NUMI, OTCQX: NUMIF) hat bei der British Columbia Securities Commission eine vorübergehende Management-Stopp-Handelsanordnung (MCTO) beantragt, aufgrund von Verzögerungen bei der Einreichung seiner geprüften Jahresabschlüsse für das am 31. August 2024 endende Geschäftsjahr. Das Unternehmen erwartet, die Frist vom 29. November 2024 zu verpassen, plant jedoch, die Jahresunterlagen bis zum Jahresende abzuschließen. Numinus wird während der Verzögerungsphase alle zwei Wochen Statusberichte herausgeben und hat einen Handelsstopp für Insider eingeführt. Das Unternehmen bestätigt, dass es sich nicht in einem Insolvenzverfahren befindet und alle wesentlichen Informationen offengelegt wurden.
- None.
- Delayed filing of annual financial statements and MD&A
- Implementation of Management Cease Trade Order
- Insider trading blackout imposed
The Company is requesting the MCTO in order to secure additional time to finalize its Audited Financial Statements, the related MD&A and the applicable CEO and CFO certifications (the "Annual Filings"). The delay in filing the Annual Filings is a result of unexpected delays experienced by the Company. The Company is working with its accounting team to prepare the Financial Statements and respond to all queries. It is the Company's reasonable expectation that the Annual Filings will be finalized by the end of the year.
By way of background and as required by the BCSC, the Company notes the following:
- The Company is required to file its Annual Filings all in accordance with IFRS within 120 days after the end of its completed financial year, such date being November 29, 2024 (the "Annual Filing Deadline") as required by National Instrument 51-102 Continuous Disclosure Obligations ("NI 51-102"). The Company does not anticipate that it will be able to complete the Annual Filings on or before the Annual Filing Deadline.
- The Company is working diligently to prepare and file the Annual Filings by the end of the year, subject to its auditors' staff availability.
- The Company confirms that it intends to issue a status report on a bi-weekly basis, for as long as it remains in default of the Annual Filing Deadline in respect of the Annual Filings.
- The Company is not subject to any insolvency proceedings.
- There is no other material information concerning the affairs of the Company that has not been generally disclosed.
The Company has imposed an insider trading blackout pending the filing of the Annual Filings and will comply with the alternative information guidelines described in National Policy 12-203 Management Cease Trade Orders during such period.
About Numinus
Numinus Wellness Inc. (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms of depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society. Learn more at www.numinus.com and follow us on LinkedIn, Facebook, and Instagram.
Forward Looking Statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect", and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. In particular, and without limitation, this news release contains forward-looking statements respecting the Company's reasonable expectation that the Annual Filings will be finalized by late December 2024 or early January 2025. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements, including the results of further research into MDMA, if any, the FDA and other regulators' decisions in respect of MDMA and other psychedelic medications, restrictions that may be placed on the use of psychedelic compounds by regulatory authorities; safety and efficacy of psychedelic-assisted therapy; acceptance, uptake and commercialization of psychedelic assisted therapy, if any; dependence on obtaining regulatory approvals, and other risks that are set forth in our annual information form dated November 29, 2023, and available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. Numinus does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
For more information:
Investor Contact: Craig MacPhail invest@numinus.com
View original content:https://www.prnewswire.com/news-releases/numinus-applies-for-management-cease-trade-order-302307557.html
SOURCE Numinus Wellness Inc.
FAQ
Why did Numinus Wellness (NUMIF) request a Management Cease Trade Order in November 2024?
When will Numinus (NUMIF) file its delayed 2024 annual financial statements?
What measures has Numinus (NUMIF) implemented during the financial filing delay?
